|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the EYE 10-K filed Mar 1, 2007. Cataract
Treatment. The largest
segment of the ophthalmic surgical products market is the treatment of
cataracts. Cataract extraction followed by IOL implantation is one of the most
common surgical procedures performed in the United States and most other
developed nations. As estimated by MarketScope, approximately 2.9 million
cataract procedures were performed in the United States and over 14.1 million cataract
procedures were performed worldwide in 2006.
MarketScope estimates that the global cataract surgery market, which
includes sales of IOLs, phacoemulsification equipment, viscoelastics and other
related products, was approximately $3.4 billion in 2006 and is projected to
grow at a compound annual growth rate of approximately 10% from 2006 to 2011.
The data in this report attributed to MarketScope is used with the permission
of MarketScope.
During cataract surgery, patients are often treated using phacoemulsification, a process that uses ultrasound waves to break the natural lens into tiny fragments that can be removed from the eye. Viscoelastics are used during cataract surgery to protect the inner layer of the cornea, provide lubrication and maintain space in the anterior chamber of the eye and the capsular bag in the posterior chamber (which houses the lens), allowing the eye to maintain its shape. The following table sets forth the estimated revenues for each component of the global cataract surgery market in its various components for the year 2006 according to MarketScope (in millions):
This excerpt taken from the EYE 10-K filed Mar 14, 2006. Cataract
Treatment. The largest segment of the ophthalmic surgical
products market is the treatment of cataracts. Cataract extraction followed by
IOL implantation is one of the most common surgical procedures performed in the
United States and most other developed nations. As estimated by MarketScope,
approximately 2.8 million cataract procedures were performed in the United
States and over 13.3 million cataract procedures were performed worldwide in
2005. MarketScope estimates that the global cataract surgery market, which
includes sales of IOLs, phacoemulsification equipment, viscoelastics and other
related products, was approximately $3.1 billion in 2005 and is projected to
grow at a compound annual growth rate of approximately 9% from 2005 to 2010.
The data in this report attributed to MarketScope is used with the permission
of MarketScope.
During cataract surgery, patients are often treated using phacoemulsification, a process that uses ultrasound waves to break the natural lens into tiny fragments that can be removed from the eye. Viscoelastics are used during cataract surgery to protect the inner layer of the cornea, provide lubrication and maintain space in the anterior chamber of the eye and the capsular bag in the posterior chamber (which houses the lens), allowing the eye to maintain its shape.
The following table sets forth the estimated revenues for each component of the global cataract surgery market in its various components for the year 2005 according to MarketScope (in millions):
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for EYE: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
